Shareholders Equity: The sum of preferred and common equity items.
TELA Bio, Inc. (TELA) had Shareholders Equity of $1.56M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$20.69M |
|
$-8.60M |
|
$6.62M |
|
$14.06M |
|
$28.24M |
|
$-7.55M |
|
$-1.05M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-7.55M |
|
$-7.31M |
|
45.42M |
|
45.42M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$56.05M |
|
$2.21M |
|
$5.54M |
|
$61.59M |
|
$16.98M |
|
$41.49M |
|
$43.05M |
|
$60.03M |
|
$1.56M |
|
$0.10M |
|
|
Shareholders Equity |
$1.56M |
40.34M |
|
| Cash Flow Statement Financials | |
$-23.35M |
|
$0.65M |
|
$-0.10M |
|
$52.94M |
|
$29.96M |
|
$-22.97M |
|
$2.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.30 |
|
-- |
|
-- |
|
0.96 |
|
26.65 |
|
67.98% |
|
-36.51% |
|
-36.51% |
|
-- |
|
-41.58% |
|
-41.58% |
|
$-23.71M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.57 |
|
1.84 |
|
49.04 |
|
-552.52% |
|
-8352.18% |
|
-13.97% |
|
-19.98% |
|
$0.04 |
|
$-0.52 |
|
$-0.51 |
|